SCHEMBL15536403

SCHEMBL15536403

CC1(OCc2cc(F)c(C(=O)NS(C)(=O)=O)cc2Cl)CCC(F)(F)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 1.00
SCN5A Q14524 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15535941 0.80 SCN9A (1.00) SCN9ASCN5A
SCHEMBL366524 0.79 SCN9A (0.65) SCN9ASCN5A
SCHEMBL15536404 0.77 SCN9A (0.76) SCN9ASCN5A
SCHEMBL16448571 0.74 SCN9A (1.00) SCN9A
SCHEMBL15535867 0.74 SCN9A (1.00) SCN9ASCN5A
SCHEMBL15558736 0.74 SCN9A (0.57) SCN9A
SCHEMBL370936 0.73 SCN9A (0.88) SCN9ASCN5A
SCHEMBL16239821 0.73 SCN9A (0.66) SCN9ASCN5A
SCHEMBL16387268 0.72 SCN9A (1.00) SCN9ASCN5A
SCHEMBL16239561 0.72 SCN9A (0.64) SCN9ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855428-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN Genentech, Inc. (US) 2015-04-08 EP disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 US disclosed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 WO disclosed